I am grateful that medullary thyroid cancer (MTC) does not include typical chemotherapy options like other cancers.
All articles by Christine Pudel, RN, MTC Contributor
For HCPs, I think it might be helpful to point out both the dos and the don’ts from the perspective of someone living with medullary thyroid carcinoma (MTC).
I deal with the persistent side effects of medullary thyroid cancer (MTC) as well as the treatments I received for it.
Shortly after I was diagnosed with medullary thyroid carcinoma (MTC), I created a blog that reflects my progress and some silver linings.
Before I was diagnosed with medullary thyroid cancer (MTC), I didn’t really have any experience with the health care system as a patient.
I believe it is important for health care professionals to understand the financial burden placed on patients and their families after a diagnosis.
One question that will arise for most if not every patient, is the question of prognosis. Whenever I did bring up that question, I never received an answer.
Being diagnosed with medullary thyroid carcinoma (MTC) likely means one loses his or her thyroid.
As a 25-year-old young adult receiving a cancer diagnosis, starting a family had still been a dream, one that became very uncertain if not obsolete.